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ABSTRACT 
 
 Endovascular embolization is an interventional procedure to seal off diseased 
vasculature from systemic circulation. Shape memory polymer (SMP) foams are a 
promising embolic material that can undergo shape change when exposed to stimuli, 
exhibit a positive healing response, and aid in rapid occlusion. SMP foams are porous 
materials that are composed of struts and membranes that pose a risk of generating 
particles during device fabrication or delivery. Herein, a sheathed embolization device 
(SED) was designed, fabricated, and tested to occlude a left atrial appendage (LAA) and 
to mitigate the generation of foam particles.  
The SED consists of a thin polyurethane membrane that fully encapsulates the 
SMP foam, and is able to undergo shape change from a compressed state to an expanded 
state. Material properties of the device were characterized with differential scanning 
calorimetry, scanning electron microscopy, and Fourier transform infrared spectroscopy. 
The SED was tested in terms of its ability to occlude a patient-derived LAA model, its 
deliverability, and its ability to reduce particles.  
Results from the studies demonstrate the SED’s ability to be delivered minimally 
invasively, reduce particles, and occlude mock vasculature. Upon actuation in body-
temperature fluid the SED achieved a 10x diameter expansion, making it ideal for 
endovascular applications. These preliminary results support the potential to utilize SEDs 
to occlude vasculature while mitigating the risk of unintended ischemia due to device-
based particles. The results also demonstrate the potential to integrate the SED with third-
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party devices or components to develop functional embolization devices, such as left atrial 
appendage closure devices.  
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NOMENCLATURE 
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1. INTRODUCTION 
 
1.1 Shape memory polymer (SMP) foams 
 
Polyurethane SMP foams are attractive materials for endovascular applications. 
SMP foams are capable of being compressed to fit inside a catheter and then actuating 
once exposed to body heat and water inside vasculature, achieving up to a 70-fold volume 
expansion [1]. SMPs consist of net points and switching segments that are responsible for 
shape change. To program SMPs, the material is heated above its glass transition (Tg) 
temperature, and an external stress is applied to deform the material to its secondary shape. 
The secondary shape is then fixed by cooling the material under constant load. When 
exposed to a stimuli, the material returns to its primary shape (Figure 1.1) [2].  
The porous architecture of the foams provides a large surface area for rapid clotting 
and connective tissue infiltration [3]. Polyurethane based SMP foams have also been 
shown to be biocompatible in a porcine animal model, producing a reduced inflammatory 
response when compared to suture materials (silk and polypropylene), cellular infiltration, 
and endothelialization [4]. These materials are also highly tunable to cater to specific 
endovascular applications, and have been shown to achieve complete occlusion within 5 
minutes [3]. 
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Figure 1.1: Programming SMP materials. (A) The primary shape is (B) heated above its Tg. (C) An 
external stress is applied and held while (D) the material is cooled below its Tg. (E) Heating the SMP 
material above its Tg causes the material to actuate and return to its primary shape. 
 
 
 
1.2 Left atrial appendage closure 
 
Closure of the left atrial appendage is a treatment option for patients suffering from 
atrial fibrillation to reduce their risk of stroke. Atrial fibrillation (AF) is an abnormal heart 
rhythm that is associated with significant morbidity and mortality. It affects roughly 6.1 
million in the USA, which is expected to increase to 12 million by 2050 [5]. Patients 
suffering from AF have an irregular heart rhythm that results in a pooling of blood in the 
atria and formation of clots in the appendage (Figure 1.2). The formation of clots increases 
risk of stroke, which is the third leading cause of death in the USA [6]. Data suggests that 
15% of all strokes are attributable to AF [7]. In the mid-1950s, it was found that the 
majority of clots in patients with AF were formed in the LAA. This discovery stimulated 
the development of LAA exclusion treatments [5]. 
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Figure 1.2: Clot formation in the left atrial appendage as a result of atrial fibrillation [8]. 
 
 
 
Presently, the treatment of choice for preventing stroke in AF patients is oral 
anticoagulation therapy. However, oral anticoagulation therapy is not well tolerated by 
patients due to its interaction with other medications, potential for bleeding, and narrow 
therapeutic window [9-11]. Given that fewer than 50% of patients with AF are considered 
candidates for oral anticoagulation therapy, and that the LAA is the source of 90% of atrial 
thrombi, LAA closure is a desirable treatment [12]. LAA closure can be performed 
surgically or percutaneously with epi- or endo-cardial devices (Figure 1.3) [13].  
 Percutaneous closure of the LAA is associated with a less invasive procedure, a 
faster recovery time, and reduced risk of bleeding. Currently, the WATCHMAN (Boston 
Scientific) is the only FDA-approved LAA closure device, but several other devices have 
received CE marking or are in development [13]. In general, these devices are composed 
of a self-expanding nitinol frame with barbs, or anchors, that exclude the LAA while 
engaging the surrounding tissue to prevent migration. Complications from these devices 
include air embolism, pericardial effusions, tamponade, tissue tearing, device 
embolization, and stroke [11].  
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Figure 1.3: Catheter-based LAA occlusion devices used clinically. (A) WATCHMAN (Boston 
Scientific); (B) AMPLATER Cardiac Plug (St. Jude); (C) AMPLAZER Amulet (St. Jude); (D) 
Coherex WaveCrest (Coherex Medical); (E) LARIAT (SentreHeart); (F) Occlutech LAA occluder 
(Occlutech); (G) Transcatheter patch (Sideris); (H) LAmbre (Lifetech Scientific) [13]. Reprinted from 
Eurointervention, with permission from Europa Publishing.  
 
 
 
Partial to full volumetric occlusion of the LAA cavity, as opposed to just sealing 
the entrance to the appendage, may improve outcomes. Non FDA-approved devices have 
partially filled the appendage cavity with polyester mesh, nitinol mesh, expanded 
polytetrafluoroethylene (ePTFE), and polyurethane foam [14]. A goal of this thesis is to 
design an embolization device composed of SMP foam that is capable of occluding a LAA. 
The proposed embolization device should also be able to integrate with hard materials, 
like nitinol, to improve fluoroscopic guidance and cavity sealing. A method to protect the 
SMP foam from hard materials will also be discussed and investigated in this thesis.  
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1.3 Particulate matter 
 
Particulates are “mobile undissolved particles [that are] unintentionally present” 
in media [15]. The FDA requires medical device manufacturers to evaluate the size and 
amount of particulates generated by device materials, manufacturing processes, and the 
final device [16, 17]. Implanted devices that are upstream of brain vasculature pose an 
unique and significant risk of generating particulates that can cause transient ischemic 
attacks or strokes [18]. Therefore, procedural or device controls are needed to mitigate the 
risk. 
 The intended application and design of the embolization device discussed in this 
thesis is especially at risk for generating harmful particulates. To mitigate the risk and 
generation of device-related particulates, a thin polymeric membrane will encapsulate the 
SMP foam and serve as a barrier and emboli protector. An adapted protocol will then 
quantify the amount of generated particulates and verify the membrane is functional.  
 
 
1.4 Approach 
 
Incorporation of SMP foam in a LAA closure device may result in rapid clotting, 
endothelialization, and tissue ingrowth that biologically fixates the device within the 
appendage. As a result, adverse events, such as device thrombosis, device migration, and 
incomplete occlusion may be reduced. Current devices generally lack a volume filling 
occlusion member, and serve their function of preventing stroke by sealing the ostium of 
the LAA.  
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To improve volume occlusion, a device comprised of SMP foam encapsulated 
within a membrane will be fabricated. The sheathed SMP occlusion device can then be 
integrated into existing devices or be used individually to embolize vasculature. The 
encapsulated SMP foam can be attached to proximal and distal marker bands to enable 
fluoroscopic guidance and device delivery. The membrane will function as a filter between 
the SMP foam and surrounding environment to capture any foam particulates that are 
generated during delivery. The membrane may also aid in endothelialization of the device. 
Additional features include a detachment mechanism that can connect to a delivery cable. 
The proposed device is intended to improve occlusion times, reduce particulate 
generation, and serve as an adjunct for predicate occlusion devices. 
 
 
1.5 Summary of thesis 
 
An SMP-based embolization device that can be integrated with hard materials, 
without increasing the generation of device-related emboli, is highly desirable. A potential 
application of an embolization device comprised of SMP foam and nitinol is the closure 
of LAAs. With that in mind, the goals of this thesis is to design, fabricate, and test a 
sheathed embolization device (SED) that is capable of occluding a LAA and mitigating 
the generation of device-related emboli.  
 Chapter 2 discusses suitable SMP foams to occlude a LAA. Criteria for foam to be 
successful in the endovascular embolization of the LAA is discussed and investigated. A 
method to maximize the expansion ratio of foam is introduced and investigated. The 
thermal properties of SMP foam is characterized with differential scanning calorimetry 
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(DSC) and reported. The morphology of SMP foam is visualized with light microscopy 
and scanning electron microscopy (SEM), and its impact on endovascular outcomes is 
discussed. Lastly, the rate at which SMP foams actuate at body temperature is investigated 
as a function of its geometry.  
 Chapter 3 describes the rationale, design, and fabrication of a SED. The design of 
the device is based on predicate devices that are used for LAA closure, and is presented. 
A thorough literature review highlights materials that are used in cardiovascular 
applications, such as capturing emboli or occluding LAAs. Several materials are 
investigated for their potential use to encapsulate SMP foam. Several processes, such as 
thermoforming, are discussed in relation to fabricating devices. A suitable material is 
selected to function as membrane to encapsulate SMP foam and capture emboli. The 
chemical, thermal, and morphological properties of the membrane material is 
characterized and presented. The final device composition and fabrication process is 
presented and justified.  
 Chapter 4 describes the test methods and testing of the final device. The crimped 
diameter of the devices were recorded and evaluated for their ability to be delivered 
minimally invasively. Crimped devices were submerged in bovine blood to determine if 
the devices actuate or form thrombus. Adsorption of blood and formation of thrombus was 
analyzed gravimetrically and visually with SEM. Devices were also delivered into an 
anatomic model of the LAA. The anatomic model was based on computed tomography 
(CT) data from a human patient. Gaps between the device and appendage opening was 
quantified with image processing. Qualitative features of delivery such as difficulty, 
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device recapturing, and device deployment are reported. Lastly, particle generation from 
SMP foam and SMP foam encapsulated by a membrane is reported. The particle protocol 
is adapted from a guidance document from the United States Pharmacopeia (USP).   
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2. SHAPE MEMORY POLYMER CHARACTERIZATION 
 
2.1 Introduction 
  
Identification of suitable SMP foam is essential to producing a high-performance 
implantable medical device. Certain characteristics SMP foam should possess for use in 
endovascular occlusion applications include: the ability to remain stored in their secondary 
configuration, the ability to volumetrically fill cavities upon exposure to a stimuli, positive 
blood and tissue interactions, and a tailored actuation profile. In this chapter several 
characterization techniques were employed to characterize the thermal properties that 
regulate the shape change of SMP foam, as well as the geometric architecture of SMP 
foams.  
 The results from this chapter will aid in the design and development of an embolic 
device that can potentially be used to occlude LAA’s. The purpose of the SMP for this 
application is to volumetrically fill the LAA cavity in a reasonable manner, then 
subsequently allow rapid and stable thrombus formation within the cavity. Over the span 
of 90 days the exposed surfaces of the SMP foam should become endothelialized, forming 
a neointima at the ostium of the LAA. Rodriguez et al. have demonstrated SMP foams 
ability to form discontinuous and continuous endothelial layers at 30 and 90 days, 
respectively, in a porcine aneurysm model. Further, cellular, connective, and granular 
tissue infiltration is observed within the SMP foam scaffolds, suggesting an active healing 
response [4]. Herein, several SMP foam geometries will be investigated for their ability 
to be delivered via traditional procedural techniques and their ability to fill a large LAA.  
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2.2 Materials and methods 
 
2.2.1 SMP synthesis 
 
Polyurethane SMP foams were synthesized following a three-step protocol 
previously described by Hasan et al. [19]. Briefly, isocyanate prepolymers composed of 
appropriate molar ratios of N,N,N’,N’-tetrakis(2-hydroxypropyl)ethylenediamine 
(HPED, 99%; Sigma-Aldrich Inc., St. Louis, MO), triethanolamine (TEA, 98% Sigma-
Aldrich Inc.), and hexamethylene diisocynate (HDI, TCI America Inc., Portland, OR) 
were synthesized. The isocyanate prepolymer is then reacted with a hydroxyl mixture 
blended with the remaining molar equivalents of HPED and TEA. The hydroxyl mixture 
also contained catalysts (T-131 and BL-22, Air Products and Chemicals Inc., Allentown, 
PA) and deionized (DI) water. To create foams the isocyanate prepolymer and hydroxyl 
mixture were combined with surfactants (DC 198 and DC 5943, Air Products and 
Chemicals Inc.), and a physical blowing agent Enovate (Honeywell International, Inc., 
Morristown, NJ) to create SMP foams.  
Foam formulations are denoted as HXX, where “XX” corresponds to the ratio of 
HPED to TEA equivalents. Varying the ratio of HPED to TEA enables tuning of the 
thermo-mechanical properties of the foam. Based on previous internal investigations and 
inventory, a foam composition of H40 was investigated. The mechanical properties of H40 
foams used in thesis can be found in Appendix A. 
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2.2.2 Foam processing 
  
Following foam synthesis, the bulk foam was cut into rectangles that were 7 cm 
long, 6 cm wide, and 2 cm thick using a hot wire cutter. The rectangular blocks of foam 
were then placed into fixture and penetrated by an array of pins while subjected to low 
amplitude, high frequency perturbations. This process, coined reticulation, is described by 
Rodriguez et al., and allows the creation of an open-cell network (Figure 2.3A) that allows 
blood and cellular infiltration throughout the foam matrix [20].  
 Cylindrical foams 3 cm in diameter were then cut from the reticulated foam 
rectangles using a 3D printed hole puncher. A 3 cm foam diameter was chosen to treat 
large LAA cavities, and approximates the size of large LAA closure devices. By 
approximating large LAA closure devices we can simulate the “worst-case” scenario for 
delivery and match industry standards. LAA closure devices are typically oversized by 9 
to 30% relative to the maximum LAA ostium diameter; therefore a SED with a 3 cm outer 
diameter (OD) may occlude a LAA with an ostium of approximately 23 to 27.5 mm [13, 
14].  
 The center of the cylindrical foams were then bored out with disposable biopsy 
punches (Sklar Surgical Instruments, West Chester, PA, USA) or with custom hole 
punchers, resulting in hollow cylinders (Figure 2.1). The centers were bored out to enable 
delivery through smaller catheters and to maximize expansion ratios. Table 2.1 outlines 
the foam geometries investigated in this thesis.  
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Table 2.1: Investigated H40 foams. Small, medium, and large (S, M, and L) designations correspond 
to pore sizes of approximately 1000, 1500, and 1800 μm, respectively. Foams of each pore size will 
have 0 to 20 mm bores in the center. 
Pore Size 
(μm) 
~1000 (Small) ~1500 (Medium) ~1800 (Large) 
Bore Size 
(mm) 
0 5 10 15 20 0 5 10 15 20 0 5 10 15 20 
 
 
 
 
Figure 2.1: H40 SMP foams (30 mm OD x 20 mm length) with increasing bore diameter. From left to 
right, 0, 5, 10, 15, and 20 mm bore diameters. The percent below the foam indicates the volume relative 
to the non-bored foam. 
 
 
 
After the foams were cut into their final geometry, they were cleaned to remove 
unreacted monomers, plasticizers, and particulates. A cleaning cycle consisting of 
submerging foam in 99% isopropyl alcohol (IPA, VWR, Radnor, PA) and rinsing with 
reverse osmosis (RO) water under sonication was performed and described in Table 2.2. 
The amount of solvent used was approximately 20x the volume of foam. After cleaning, 
the foams were placed in aluminum trays with RO water and allowed to freeze in a -20°C 
freezer for 12 h before freeze-drying in a FreeZone Freeze Dryer (Labconco, Kansas City, 
MO) for 24 hours.  
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Table 2.2: Description of foam cleaning process. 
Cleaning Step Name Time Description of Method 
RO Sonication 30 min 
Foams sonicated with RO water at 37°C in 
beaker  
IPA Sonic 1 30 min 
Previous solvent removed. Foams sonicated 
with IPA at 37°C 
RO Rinse 1 1 min 
Previous solvent removed. Foams rinsed 
with RO water to remove residual IPA 
IPA Sonic 2 30 min 
Foams sonicated with IPA at 37°C 
RO Rinse 2 1 min 
Previous solvent removed. Foams rinsed 
with RO water to remove residual IPA 
IPA Sonic 3 30 min 
Foams sonicated with IPA at 37°C 
RO Rinse 3 1 min 
Previous solvent removed. Foams rinsed 
with RO water to remove residual IPA 
Final RO Sonic 30 min 
Foams sonicated with RO water at 37°C  
Final RO Rinse 1 min 
Previous solvent removed. Foams rinsed 
with RO water  
 
 
 
2.2.3 Differential scanning calorimetry (DSC) 
  
Each batch of foams synthesized had their dry and wet glass transition (Tg) 
temperatures characterized using a Q-200 dynamic scanning calorimeter (DSC) (TA 
Instruments Inc., New Castle, DE). The dry and wet Tg of the foam can help elucidate at 
what temperatures the foams will actuate at under dry and wet conditions. These 
temperatures have important implications in terms of storing the foam samples, and 
understanding the expansion kinetics when the foam is inside the body. In other words, 
dry and wet Tg can determine whether or not the foam will expand prematurely outside 
the body; or if it will expand once inside the body. 
Foam samples (3-10 mg; N = 3) were taken from already processed foam cylinders. 
Samples used for dry Tg analysis were hermetically sealed and packed in aluminum pans. 
The DSC protocol specified an initial sample cooling to -40°C at a rate of 10°C/min, then 
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holding it isothermally for 2 min. Following the cooling cycle, a heat ramp at a rate 
10°C/min to 120°C occurred. The cooling and heating cycle was then repeated twice; the 
last heating cycle was analyzed to quantify dry Tg values of the foam. The Tg measurement 
was based on the inflection point of the thermal transition curve using TA Instruments 
software.  
 Wet Tg foam samples were submerged in RO water at 50°C for 15 minutes to allow 
full plasticization. Samples were then removed from water, sandwiched between 
Kimwipes (Kimberly-Clark Professionals, Roswell, GA), and press dried with a 
mechanical press (2 tons, 30 seconds). Samples were then weighed (3-10 mg) and placed 
in aluminum pans with a vented lid. The DSC protocol decreased the temperature to -40°C 
at 10°C/min and held it isothermally for 2 minutes. The temperature was then increased 
to 80°C at 10°C/min. The wet Tg measurement was based on the inflection point of the 
thermal transition curve using TA Instruments software. 
 
 
2.2.4 Imaging 
  
Foam pore sizes, strut thickness, and cell structure were analyzed by taking 
magnified images of thin slices of foam using a high resolution light microscope (VHX-
5000, Keyence Corporation, Osaka, Japan) and a scanning electron microscope (SEM, 
Joel NeoScope JCM-5000, Nikon Instruments Inc., Melville, NY). Transverse and axial 
slices of foam were prepared by cutting foam with a razor-sharp scalpel. Foam samples 
were mounted onto the light microscope stage and imaged at different magnifications (20x 
to 200x). Keyence software allowed for real-time depth composition and 2D/3D stitching 
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of the foam samples, thus providing focused images. Additionally, length measurements 
of the foam were taken with Keyence software, wherein the pore diameter was taken as 
the maximum diameter. Ten measurements were taken to account for variation in pore 
sizes.  
 SEM samples were prepared by first thinly slicing sections from bulk foam with a 
razor sharp scalpel. The thin slices were then mounted onto a SEM platform with carbon-
tape and placed under vacuum at room temperature overnight. The samples were then 
sputter coated with gold for 60 s at 20 mA using a Cressington sputter coater (Ted Pella 
Inc., Redding, CA). Samples were then placed in the SEM chamber and imaged under 
high vacuum at a voltage of 10 kV or 15 kV.  
 
 
2.2.5 SMP foam actuation 
  
Actuation, or expansion, studies are performed to characterize how quickly SMP 
foams will expand inside the body, and how large they will expand. Ideally, the SMP 
foams should expand in an appropriate time that prevents premature expansion inside the 
delivery catheter and allows full expansion inside the body cavity.  
Prior to performing the actuation studies, crimped foam samples were prepared. 
Processed SMP foam cylinders described in Table 2.1 were crimped over a 0.008” nitinol 
wire using a SC250 Stent Crimper (Machine Solutions Inc., Flagstaff, AZ, USA). The 
SC250 Stent Crimper was set to a crimping pressure of 80 pounds per square inch (PSI) 
at 100°C.  Foam samples were allowed to equilibrate to 100°C and reach a rubbery state 
before crimping. Once equilibrated the SC250 Stent Crimper was closed and cooled to 
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room temperature. The foam samples were then removed and their crimped diameters 
measured with calipers. 
Actuation studies were conducted by loading crimped samples to a fixture, 
submerging in a heated water bath, and imaging at specific time points. The samples were 
loaded to a fixture to keep the threaded nitinol wire, and sample, taut. The water bath was 
heated to approximately body temperature (37.5°C). Samples were then placed into the 
water bath and imaged every 30 seconds using a digital camera (PowerShot SX230 HS, 
Canon Inc., Tokyo, Japan) until they foams were fully expanded. The images were then 
analyzed with either ImageJ (NIH, Bethesda, MD) or an interactive MATLAB program 
(MathWorks Inc., Natick, MA, USA); the details of which can be found in Appendix B 
and C.  
 
 
2.3 Results  
 
2.3.1 Imaging 
 
 Light microscopy and SEM imaging revealed foam architecture and the impact 
reticulation has on foam processing. Figure 2.2 depicts an open-cell foam that has pore 
measurements overlaid. SEM images show partially closed-cell and open-cell morphology 
observed in foam (Figure 2.3).   
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Figure 2.2: Light microscope image of a predominantly open-cell foam with overlaid pore 
measurements. 
Figure 2.3: SEM images of H40 SMP foam with an (A) open-cell pore and a (B) partially close-cell 
pore. Asterisk indicates foam strut; Arrowhead indicates membrane. Synthesis of foam courtesy of 
Dr. Marziya Hasan, Alexa Easely, and Grace Fletcher. 
Due to the foaming process thin residual membranes are observed between struts. 
The membranes form a predominantly closed cell structure, and can be removed by 
secondary physical processes such as hydrolysis, oxidation, heat, plasma etching, or 
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mechanical treatment [21, 22].  A closed cell microstructure may not be conducive for 
embolic materials as the lack of interconnected pores limit cellular infiltration during 
healing. Further, a closed cell microstructure may generate a large pressure gradient when 
deployed in the body, potentially causing the material to migrate after deployment [4, 21]. 
For these reasons mechanical reticulation was carried out, successfully resulting in a 
predominantly open-cell microstructure as shown in Figures 2.2 and Figure 2.3.   
 Mechanical reticulation did not eliminate membranes entirely, but instead resulted 
in pseudo-open cell structures. Figure 2.3B shows a membrane that has micro-holes 
perforated through it. For the application of occluding a LAA the lack of completely open 
cells is not anticipated to be a major issue. Since the LAA is a terminal cavity with no 
downstream vasculature the danger of device migration downstream is non-existent, 
therefore a pressure gradient from a closed-cell structure is a low-risk situation. The key 
benefits of an open-cell microstructure for this application is rapid occlusion due to the 
formation of stable thrombus triggered by flow stagnation and recirculation through the 
interconnected foam matrix; as well as a cellular infiltration that improves the healing 
response [23, 24]. For this thesis, 0.008” nitinol wires punctured the membranes to provide 
a more open-cell structure. Despite incomplete removal of the membranes, 0.008” 
punctures are large enough to allow cells to infiltrate throughout the volume of the foam 
matrix.  
 Reticulation also affects the overall physical properties of the SMP foam. Blair et 
al. have reported reticulated foams have a decrease in the resistance to mechanical 
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compression [25]. Less resistance to compression may result in tighter crimping of the 
foam, thus decreasing the crimped diameter of the foam. A more compressed foam is 
beneficial to clinicians as it enables delivery through a low-profile catheter. A potential 
drawback of mechanical reticulation of foams is the potential for strut fracture and foam 
debris. It has been shown that reticulation results in significantly higher levels of particles 
when compared to a non-reticulated foam [26]. Within this thesis an approach to mitigate 
particle-release due to mechanical reticulation includes the encapsulation of the foam by 
a filter membrane.  
 
 
2.3.2 Pore size 
  
Eight foam batches were imaged in the transverse and axial directions, and were 
categorized as small (S), medium (M), or large (L) pore. Table 2.3 summarizes the pore 
sizes of each foam batch, and their respective pore classification. Based on the results in 
Table 2.3, foams were cut in either the axial or transverse direction to achieve a suitable 
pore sizes. Anisotropic pore cells were also apparent from the difference in pore size 
between axial and transverse slices, which is typically seen in blown foams [27].  
  
 20 
 
 
Table 2.3: Axial and transverse pore sizes of foam batches.  
Pore 
Classification 
Foam Batch Axial Pore Size (μm) 
Transverse Pore Size 
(μm) 
Small 
(~1000 μm) 
16011RCHAE01 1216 ± 189 906.6 ± 114 
160701RCHPEDGF06 1047 ± 133 1051 ± 228 
160525PEDAE01 1079 ± 135 813.9 ± 114/4 
Medium 
(~1500 μm) 
160511PEDMH02 1537 ± 186 1024.5 ± 121.7 
160515PEDAE03 1527.83 ± 252 1022.5 ± 173 
150913RCHMH04 1244.9 ± 245.1 1318.2 ± 175.15 
161004PEDAE01 1564 ± 300.5 1089.9 ± 195 
Large 
(~1800 μm) 
160929PEDAE01 1739.4 ± 359 927.8 ± 170 
  
 
 
Pore size is believed to affect several key characteristics of foam performance. 
Landsman et al. performed mechanical analysis on several pore sizes and reported that 
foams with smaller pore sizes exert a greater radial force due to increased foam density 
[3]. Radial force is clinically significant as too low of a radial force poses a risk of the 
foam migrating, whereas a high radial force poses a risk of bursting or perforating the 
vessel. Fortunately, vessel rupture from high radial force is not a realistic risk of the 
present foam compositions considering Landsman et al. oversized similar foams by 50% 
to the target vessel and reported a radial force significantly lower than the required rupture 
force [3]. Device migration due to low radial force is a concern, however. To mitigate the 
risk of the foams migrating out of the LAA a nitinol frame may anchor the foam to the 
vessel wall. The WATCHMAN LAA closure device by Boston Scientific prevents device 
migration by incorporating metal anchors that engage surrounding tissue, in addition to 
the radial outward force from their nitinol cage [28].  
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Pore size, and thus foam density, also affects expansion rates. Smaller pore sizes, 
or higher foam density, delays water from penetrating and plasticizing the foam [3]. As a 
result, foam may not expand as fast when compared to larger pore foam.  
 
 
2.3.3 Thermal properties 
  
DSC was used to characterize the thermal properties of the thermoset SMP foams 
in wet and dry environments. In particular, the transition temperature at which foams 
undergo shape change corresponds to the Tg. Table 2.4 shows that the average dry Tg of 
all investigated foams was between 59°C and 64°C with a max deviation of ± 2.4°C. Based 
on the dry Tg results the foams may be stored at room temperature if the surrounding 
environment is dry. The wet Tg was between 13 and 16°C, indicating that the foam will 
undergo shape change when placed into the body.  
 Pore size did not have a significant effect on the transition temperatures of the 
foam. This is expected as the foams were all of the same composition (i.e. H40). By 
varying the ratio of HPED to TEA in the foam formulation the transition temperatures can 
be precisely controlled. It is believed that the secondary hydroxyl group within HPED can 
present steric hinderance to rotational motion around the urethane linkage, and HPED can 
provide a higher crosslink density in comparison to TEA; thus increasing the Tg [22]. 
Landsman et al. supported that logic by showing that an H20 composition had a Tg 20°C 
less than the higher HPED content H60 composition [3].   
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Table 2.4: Wet and dry Tg temperatures for small, medium, and large pore foams.  
Pore Size Average Dry Tg (°C) Std. Dev. Average Wet Tg (°C) Std. Dev. 
Small Pore 59.53 1.45 13.52 1.84 
Medium Pore 61.65 2.40 15.34 2.99 
Large Pore 63.24 0.29 15.27 0.99 
 
 
 
2.3.4 Expansion profiles 
  
Characterizing the rate of expansion and final crimped diameter is critical to the 
performance of an embolization device. The crimped diameter regulates what size delivery 
catheter is suitable; typically, a lower-profile delivery catheter is desired as it can access 
more vasculature. The rate of expansion of SMP foam determines whether premature or 
delayed expansion will affect procedural outcomes. Premature expansion can cause the 
device to occlude the catheter, thus preventing deployment. Incomplete, or delayed 
expansion can result in incomplete occlusion of the vasculature, prolonged procedural 
times, or migration of the device.  
 Figure 2.4 shows the final crimped diameter of the foam as a function of bore 
diameter and pore size. Pore and bore size both had an effect on the final crimped diameter. 
In general, a trend depicting a decrease in crimped diameter as bore and pore size increased 
was observed. As bore and pore size increased the foam density decreased, thus allowing 
the foam to be crimped to smaller diameters. 
A two-way analysis of variance (ANOVA) with Tuley post-hoc multiple 
comparison was conducted to examine the effect of pore size and bore size on crimped 
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diameter of SMP foam. Main effect analysis showed increasing pore and bore size 
significantly decreased crimped diameter. However, there was no significant interaction 
between pore and bore size. Tukey pairwise multiple comparison showed a significant 
difference between the majority of bore sizes when pore size was held constant. There was 
no significant difference between pore sizes, however. Two-way ANOVA was performed 
using Graphpad Prism 7 (Graphpad Software, Inc, La Jolla, CA).  
Table 2.5 shows increasing bore and pore sizes increase the expansion ratio of 
foams, wherein the expansion ratio is defined as:  
𝐸𝑥𝑝𝑎𝑛𝑠𝑖𝑜𝑛 𝑅𝑎𝑡𝑖𝑜 =  
30 𝑚𝑚
𝐶𝑟𝑖𝑚𝑝𝑒𝑑 𝐷𝑖𝑎𝑚𝑒𝑡𝑒𝑟 (𝑚𝑚)
 
A max expansion ratio greater than 10 and a 61-fold volumetric expansion was recorded.  
 
 
 
 
Figure 2.4: Final crimped diameter as a function of pore and bore diameter. The ID of a 12 Fr catheter 
is taken as 3.75 mm (N ≥ 3). 
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Table 2.5: The average expansion ratios ± standard deviation of H40 foams as a function of bore and 
pore size (N ≥ 3). N/A corresponds to insufficient data due to limited availability of foams. 
Bore Size (mm) Small Pore Medium Pore Large Pore 
0 7.31 ± 0.12 7.68 ± 0.15 7.49 ± 0.01 
5 7.85 ± 0.90 7.92 ± 0.20 7.73 ± 0.06 
10 7.90 ± 0.31 8.30 ± 0.33 8.16 ± 0.22 
15 8.60 ± 0.41 8.97 ± 0.17 N/A 
20 9.99 ± 0.07 10.42 ± 0.19 N/A 
 
 
 
 The rate of expansion of SMP foams as a function of pore and bore diameter is 
shown in Figure 2.5. Most foams were able to expand to their original diameter in body-
temperature water in under 10 minutes. To identify any trends in the data an index was 
selected for each data set and compared. The index was taken as the time it took the foam 
to expand to half its expanded diameter (Appendix D). No statistical or qualitative trend 
was observed. 
Possible explanations for the lack of observable trends include: compromised 
mechanical properties due to boring of the foam that affected shape memory, irregular 
crimping, temperature fluctuations, or image analysis error.  
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Figure 2.5: Expansion profiles as a function of pore and bore diameter.  
 
 
 
 A potential complication for passively-actuated embolization devices is premature 
expansion in the delivery catheter. To compound the risk, it is common practice to flush 
the delivery catheter containing the embolization device with saline to purge air and 
prevent air embolisms [28, 29]. To mitigate premature expansion of the foam the Tg may 
be tailored appropriately. Furthermore, the encapsulation of the SMP foam within a 
membrane or nitinol frame may be able to contain the foam enough to allow the clinician 
to deliver the device.  
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3. DESIGN AND FABRICATION OF A SHEATHED EMBOLIZATION DEVICE 
 
3.1 Introduction 
 
 While SMP foam is a promising material for embolization devices, there exists a 
risk of unintended ischemia due to foam particulates entering the blood stream as emboli 
[26, 30]. This risk is compounded if SMP foam is in contact with nitinol mesh, wire, or 
other hard materials that can mechanically shear chunks of the low-density foam. 
Fabrication of a stand-alone device comprised of SMP foam and an emboli-capturing 
membrane may prevent foam based emboli from entering the bloodstream, and expand 
the commercial and clinical utility of SMP foams. A successful sheathed embolization 
device (SED) comprised of SMP foam could potentially be integrated with metals or 
predicate devices to improve the current standard of care for embolization procedures.  
Additional concerns for developing a stand-alone SED include the mechanism of 
delivery and deployment, as well as imaging under fluoroscopy. Two popular LAAC 
devices, the WATCHMAN and Amplatzer Cardiac Plug (ACP, St. Jude Medical, 
Plymouth, Minnesota), are secured to a delivery cable and deployed by unscrewing the 
delivery cable [31, 32]. These devices are repositionable and retrievable. The 
WATCHMAN, and new versions of the ACP, come pre-loaded inside a delivery system 
and are deployed by holding the delivery cable fixed while slowly withdrawing the 
delivery catheter; as opposed to pushing the device [32, 33]. Fluoroscopic imaging is 
critical to proper device placement, and is achieved via marker bands on the delivery 
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system (i.e. access sheaths and delivery catheters) and from the inherent radiopacity of the 
nitinol that makes up the bulk of LAAC devices [14].   
 Within this chapter, a SED utilizing SMP foam as the main embolic material and 
a thin encapsulating membrane to provide emboli protection has been developed. The SED 
prototype also incorporates a delivery mechanisms that allows for fluoroscopic imaging 
to aid in device positioning. Within this chapter the material and design rationale will be 
provided, as well as the details for fabricating the SED. Lastly, components of the SED 
will be characterized to provide justification for their use, as well as insight to future 
improvements.  
 
 
3.2 Design considerations 
 
 Designing a SED that takes into consideration the clinical utility, performance, 
safety, and manufacturing concerns can improve the quality of the final device. A 
thorough literature review and analysis of adverse events regarding embolization devices, 
particularly LAAC devices, delineated design criteria and requirements specified in Table 
3.1.   
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Table 3.1: Design considerations for the development of SED.  
Design Criteria Design Requirement 
Compatible with current 
delivery systems 
Deliverable through a 12Fr catheter 
Able to treat large LAA’s  Expands to a diameter of 30 mm 
Delivery mechanism Simple and easy mechanism to delivery and deploy device 
Radiopacity Must be visible under fluoroscopy  
Particulate reduction A significant reduction in particulates between a sheathed and non-
sheathed embolization device  
Occlusion Allows blood and cellular infiltration throughout the foam matrix 
Wall apposition Device should conform to the irregularly shaped LAA wall 
Cost and ease of manufacturing Devices should be assembled in a cost and time efficient manner 
Integration with hard materials The device should have potential to integrate with nitinol or 
predicate devices to expand the clinical and commercial utility  
Ability to be recaptured  Should be retractable to be enticing to clinicians 
Biocompatibility and 
hemocompatibility   
Materials and device should: illicit a healing response, form an 
endothelial layer, and not form an unstable, undesired thrombus    
 
 
 
3.3 Device fabrication 
 
3.3.1 Summary of device design and fabrication 
 
 A SED design consisting of a SMP foam occlusion member, emboli-capturing 
membrane, and delivery system is shown in Figure 3.1 and Figure 3.3. The overall device 
geometry is a cylinder that is roughly 2 cm long and 3 cm in diameter in order to occlude 
a large LAA. A membrane will fully encapsulate the SMP foam to capture as much foam 
particulates as possible. The ends of the device will have marker bands to aid in device 
imaging, considering SMP foams not loaded with radiopaque filler have limited 
radiopacity [34, 35]. Lastly, a simple screw detachment mechanism will allow the 
clinician to deploy the device once positioned.  
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Figure 3.1: SED design concept. 
 
 
 
3.3.2 Membrane selection 
 
 Several membranes were investigated for their use in developing a SED. Common 
materials used in cardiovascular applications include polytetrafluoroethylene (PTFE), 
polyethylene terephthalate (PET), and polyurethane (PU) (Table 3.2). PTFE, PET, and 
polyurethane films were investigated in this project due to their history in vascular 
applications and availability.  
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Table 3.2. Common medical fibers and biotextiles used in cardiovascular applications. Adapted from 
[36-38]. Abbreviations PTFE: Polytetrafluoroethylene; FEP: Fluorinated ethylene propylene 
polymer; ePTFE: Expanded polytetrafluoroethylene; PET: Polyethylene terephthalate; UHMWPE: 
Ultra high molecular weight polyethylene 
Polymer Membrane Mesh Pore Size (µm) Cardiovascular Application 
Polyester  30 Blood filter (ex vivo) [36, 39] 
Cardiac support device, Left atrial appendage closure device, 
Endovascular stent-graft, Vascular Prosthesis [36] 
PTFE  
 
N/A Embolic vena cava filter, Endovascular stent-graft, Vascular 
Prosthesis, Left atrial appendage closure device [36] 
FEP N/A Embolic vena cava filter [36] 
UHMWPE N/A Left atrial appendage closure device [36] 
Polyurethane 80 – 140 Embolic protection device [36, 40, 41] 
PET 160 - 1016 Left atrial appendage closure devices [14, 37] 
ePTFE N/A Left atrial appendage closure devices [14, 37] 
Poly(carbonate) N/A Left atrial appendage closure devices [14, 37] 
Nylon N/A Left atrial appendage closure devices [14, 37] 
 
 
 
 Ultimately, thermoplastic polyurethane (TPU) films were chosen to serve as the 
membrane to protect SMP foam from shear forces while filtering emboli. Table 3.3 shows 
a comparison between the investigated materials. Common issues with the membrane 
materials included: its thickness, lack of elasticity, and its difficulty to process into 
cylinders.  
 
 
 
Table 3.3: Comparison of investigated membrane materials. 
Membrane 
Material 
Thickness 
(μm) 
Cost per 
device ($) 
Processing 
Ability 
Pore Size (μm) Use in 510(k) 
submissions (or 
medical grade) 
TPU films 23 – 28 ~0.01  Non-porous Yes 
PET 40 – 140 0.44  40 No 
UHMWPE 127 - 254 0.18  Non-porous No 
PTFE 127 - 254 0.36  Non-porous No 
ePTFE 10 - 1140 N/A  Non-porous Yes 
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3.3.3 Thermoforming 
 
 Membranes should take the form of the body-cavity they are deployed in. Should 
membranes not be formed properly, and take on a non-ideal geometry, the SED may not 
expand properly to fully occlude the body-cavity. Thermoforming was considered as a 
method to shape and process plastic membranes. Stock membrane materials were typically 
delivered in a roll or as flat sheets, and needed to be processed to a shape that can house 
foam. Thermoforming is a secondary forming process that allows users to shape plastic in 
a softened, but still solid, thermoplastic state; unlike primary forming processes that occurs 
when the thermoplastic is a melt state [42].  Mechanical thermoforming typically involves 
clamping the plastic film in a positive or negative mold, then heating the plastic above its 
Tg or near its melting point depending if its amorphous or semi-crystalline, respectively. 
After the plastic is deformed or stretched over the mold it is cooled below its softening 
range to freeze its three-dimensional shape. 
 A fixture consisting of female mold and male former was designed in SolidWorks 
(Dassaut Systemes, Waltham, MA) that would shape the plastic membranes into a closed-
end cylinder geometry (Figure 3.2). An aluminum fixture was machined via CNC 
according to the design. Membranes were wrapped around the male former, placed into 
the female mold, clamped, and then placed into a furnace. Depending on the thermal 
properties of the membrane material, the membrane was shaped into a closed-end cylinder 
similar to a tea-bag, and the excess material trimmed off.  
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Figure 3.2: Processing membranes to take on a desired geometry via thermoforming. (A) SolidWorks 
design of fixture to mechanically thermoform plastic membranes. (B) Placement of membranes into 
fixture. (C) Placement of fixture into furnace. (D) Fixed three-dimensional membrane as a result of 
thermoforming. 
 
 
 
3.3.4 Heat sealing 
 
 Heat sealing was the preferred method to seal the membrane of the SED. Two heat 
sealing methods were investigated. The first method consisted of using a solder iron that 
was heated to the membranes melting point, then applying a constant force along the areas 
to be sealed. However, this method was extremely unreliable as the contact force and 
temperature were difficult to control. The second method was to place the membrane into 
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fixture, clamp the sealing areas, and place into a furnace. This was achieved by wrapping 
the membrane around the foam and then carefully placing it into the fixture shown in 
Figure 3.2. The clamped fixture was then placed into a furnace for a set time and 
temperature, removed, and allowed to cool back to room temperature. The seams of the 
membrane that were clamped were sealed together, while the rest of the membrane and 
foam were not thermally damaged. The result was a fully encapsulated foam. Excess 
membrane material was trimmed with scissors or laser.  
 
 
3.3.5 Membrane pore creation 
 
 A Gravograph LS100 40W CO2 laser (Gravotech Inc., Duluth, GA) was used to 
cut pores into membrane materials. To do this, computer-aided design (CAD) software 
was used to make a 2-D pattern of pores and then exported to the laser-cutter software. 
The power and speed settings were set to 1% and 100%, respectively, for TPU films. The 
resolution was set to 1200 DPI.   
 
 
3.3.6 Detachment mechanism and marker bands 
 
 A simple detachment mechanism serves to deploy, reposition, and release the 
device from a delivery catheter. Similar devices use a threaded release from the delivery 
cable or an interlocking release wire for controlled release of embolic materials [43]. In 
this thesis a simple threaded release system was fabricated (Figure 3.3). Stainless steel 
(SS) was used to fabricate the detachment system due to affordability, availability, and its 
radiopaque properties. SS is a radiopaque material, allowing it to be imaged during 
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interventional procedures [44]. Placement of the SS tubes on the ends of the SED may 
serve as marker bands for the clinician to position the device properly.  
Stainless steel (SS) tubes (0.115-0.125” OD) were internally threaded (#4-40 or 
#0-80). These SS tubes were then epoxied to the ends of the SED to serve as marker bands, 
as well as to interface with the delivery cable. The delivery cable consisted of a torque 
cable that had a SS tube laser welded onto its distal end using an iWeld 990 (LaserStar, 
Riverside, RI). Filler wire and/or SS spacers were used to achieve a stable weld between 
the delivery cable and SS tube. A threaded SS rod was laser-welded at the distal end of 
the delivery cable/SS tube assembly, and interfaced with the SS marker bands on the SED. 
By simply twisting the delivery cable at the proximal end, a clinician may release the SED. 
Figure 3.3: Delivery detachment components. Asterisks indicate laser welds. 
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3.4 Device characterization 
 
3.4.1 Final device composition and fabrication 
 
 The final device composition is summarized in Table 3.4 and shown in Figure 
3.4. Detailed descriptions of the device’s composition can be found in the following 
subsections.  
 
 
 
 
Figure 3.4: A crimped SED (left) and an expanded SED (right). 
 
 
 
Table 3.4: Summary of final device composition.  
Device component Component Description 
Occlusion Member H40 SMP foam  
Membrane Porous TPU films (pore diameter = 261 μm; 10.54% porosity; 
thickness < 30 μm)  
Marker Bands SS tubes (5 mm length; 2.92 mm OD) on the proximal and distal 
ends of device 
Delivery Mechanism Screw-release; a threaded delivery cable interfaces with threaded 
marker bands on the device 
Delivery Cable A generic SS torque cable  
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The steps to fabricate and assemble a SED is shown in Figure 3.5. Briefly, a thin 
thermoplastic film is wrapped around a foam. The wrapped foam is then placed into an 
aluminum fixture. The aluminum fixture is then clamped together and placed into a 
furnace that is near the melting point of the film. While in the furnace, the film edges are 
heat sealed together. The fixture is then removed from the furnace and allowed to cool to 
room temperature. The fixture is then opened and the excess film is then trimmed or 
removed by laser. The wrapped foam is then removed and the ends are crimped. Stainless 
steel (SS) marker bands are then placed over the crimped ends and epoxied.  
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Figure 3.5: Fabrication of a SED. (A, B) A thin thermoplastic film and foam is placed into an 
aluminum fixture. The fixture is then placed into a furnace to heat seal the film together. (C) The 
edges of the film are trimmed by laser or razor. (D) The ends of the film are crimped to easily attach 
and epoxy SS marker bands. (E) The fully encapsulated foam with SS marker bands. 
 
 
 
3.4.2 Membrane characterization 
 
 Thermoplastic polyurethane (TPU) films (AU25, EU28, and EU29; SWM 
International Inc., Alpharetta, GA) were chosen as membrane materials to encapsulate the 
SMP foam. These materials demonstrated the ability to undergo compression and 
expansion alongside the SMP foam. Furthermore, improved crimped diameters were 
achieved due to the material’s thickness and elasticity. Within this section, the 
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morphology, thermal, and chemical properties of the TPU films were investigated. Other 
properties of the TPU film used in this thesis can be found in Appendix A.  
 TPU film surfaces were imaged as received with SEM following the same protocol 
in 2.2.4. A monolithic surface, as described by the manufacturer, with textured regions 
was observed (Figure 3.6). The textured regions, some of which appear to have pores, are 
most likely a result of rough handling. Despite being non-porous and a water barrier, the 
TPU films are breathable since they allow transmission of water vapor and have 
applications as wound dressings [45]. TPU films were laser-cut to create pores, as passage 
of blood and cells is critical to the performance of this application.  
 
 
 
 
Figure 3.6: SEM images of (A) AU25 (B) EU28 and (C) EU29 TPU films at x2400 magnification. 
 
 
 
 Smooth concentric pores with a diameter of 261 ± 21 μm were created with a CO2 
laser (Figure 3.7). Evidence of laser-induced melting was observed along the pore edges. 
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The pores are large enough to allow blood and cellular infiltrations, while being able to 
capture macro particulates. The theoretical porosity of the membrane was 10.54%, and 
was calculated by the following equation:  
𝑃𝑜𝑟𝑜𝑠𝑖𝑡𝑦 =  𝑉𝑜𝑙𝑢𝑚𝑒𝑝𝑜𝑟𝑒 𝑉𝑜𝑙𝑢𝑚𝑒𝑓𝑖𝑙𝑚⁄    
 
 
 
 
Figure 3.7: Light microscope images of laser created pores in TPU film; (A) 100x magnification (B) 
200x magnification.  
 
 
 
ATR-FTIR was performed, compliments of Dr. Mary Beth Browning Monroe, on 
the TPU films as received and neat H40 samples (Figure 3.8). The H40 neat samples refer 
to a non-blown, non-porous plastic that is compositionally identical the H40 foams. ATR 
FTIR spectra were obtained using a Bruker ALPHA Infrared Spectrometer (Bruker, 
Billerica, MA) with a diamond ATR crystal and analyzed with OPUS software (Bruker, 
Billerica, MA).  Thirty-two background scans of the empty chamber were taken followed 
by sixty-four sample scans in absorption mode at a resolution of 4 cm-1.  
 ATR FTIR confirmed the presence of urethane peaks at 1689 cm1 for the H40 neat 
film, as well as the TPU films. A strong C=O peak was observed for all plastics and 
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suggests hydrogen bonded urethane, which is characteristics of polyurethane polymers 
[22, 46]. A urea shoulder at ≈1647 cm1 was present in the H40 composition due to the 
reaction of isocyanates with water during synthesis. A urea shoulder is expected in H40 
foams as water is the chemical blowing agent used in traditional polyurethane foaming.  
EU28 and EU29 TPU films had a shoulder at ≈1730 cm-1 due to the presence of 
polyesters [47]. Polyester polyurethanes have been reported to undergo rapid hydrolysis 
when implanted into the body, whereas polyether polyurethanes degrade via oxidation 
[48, 49]. A membrane that degrades into non-toxic byproducts following 
endothelialization would be ideal. AU25 TPU films lacked a 1730 cm-1 shoulder and is a 
polyether polyurethane.  
 
 
 
 
Figure 3.8: ATR FTIR spectra of H40 neat films and AU25, EU28, and EU29 TPU films.  
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Figure 3.9 shows DSC thermograms of the films. TPU samples (3-10 mg; N = 1) 
received as were hermetically sealed in aluminum pans. The DSC protocol specified an 
initial sample cooling to -80°C at a rate of 10°C/min, then holding it isothermally for 2 
min. After the initial cooling, a heat ramp at a rate 10°C/min to 180°C proceeded and the 
sample was then cooled back to -80°C at the same rate. This cycle was repeated twice. Tg 
results did not change between cycles; but suspected melting points were erased on the 
following the first cycle.  
 
 
 
 
Figure 3.9: DSC thermograms showing the first heating cycle. Arrowheads indicate location of Tg. 
 
 
 
 Since the Tg of the TPU films is below freezing (-35 to -38°C), these materials are 
in their rubbery state under in-vivo conditions. Due to their low Tg temperatures, these 
films are not able to be thermoformed and do not hold a fixed shape at room or body 
temperature. As a result, these materials need to be expanded either by SMP foam, nitinol, 
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or balloons in vivo. Fortunately, the TPU films were soft and flexible enough to be 
expanded by SMP foam used in this thesis. A drawback of the thermal properties of these 
TPU films is that they do not hold their crimped geometry very well. In other words, once 
these TPU films are crimped over SMP foam they will relax; potentially clogging up the 
delivery catheter.  
An ideal membrane would have a Tg at, or near body temperature. This would 
allow the membrane to retain its crimped geometry under storage conditions (i.e. room 
temperature with low humidity), while being able to expand under in-vivo conditions. 
More information is provided in chapter 5.  
 
 
3.4.3 Delivery system 
 
 A generic torque cable was screwed into the marker bands of the SED.  SS threaded 
rods and tubes were welded to the torque cable to enable screw detachment. Two screws 
(#0-80 and #4-40) were used to detach devices. The smaller screw, #0-80, performed 
better since it required less effort to detach the device. Occasionally, difficulty was noted 
when detaching the device. This can be attributed to poor laser-welds, improper threading, 
improper device placement, and a damaged torque cable.  
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4. TESTING OF A SHEATHED EMBOLIZATION DEVICE 
 
4.1 Materials and methods 
 
4.1.1 SED expansion  
 
SEDs were fabricated from medium pore SMP foams and encapsulated with TPU 
films. The devices were threaded over 0.008” nitinol wire. The devices were crimped in a 
SC250 Stent Crimper that had a crimping pressure of 80 PSI at 80°C. The SEDs did not 
have a porous membrane and did not have SS marker bands epoxied to their ends. The 
crimped diameters of the SEDs were then recorded after 24 hours with calipers. 
 
 
4.1.2 Bovine blood interaction  
 
 Bovine blood was acquired from the Rosenthal Meat Science and Technology 
Center (Texas A&M University, College Station, TX) as part of a tissue share program. 
The blood used in this study was collected from animals euthanized for purposes unrelated 
to this research. The blood was citrated in a 3.2% sodium citrate solution to prevent 
clotting, and stored at 4°C until use.  
 Several SEDs were prepared to investigate how bovine blood affects their 
performance. Table 4.1 summarizes the SEDs used in this study. The SMP foams used in 
all SEDs were non-cleaned, non-reticulated H40 foams. No marker bands were attached 
to the ends of the SEDs. Each SED was crimped and their dry weight recorded prior to the 
studies. Polypropylene containers were rinsed with PBS (0.1 M; 7.4 pH) and filled with 
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50 mL of bovine blood. The containers were then placed into a water bath to reach a 
temperature of 37.5°C ± 0.5°C.  
 
 
 
Table 4.1: Description of SED samples used in the bovine blood study.   
SED Description Dry Weight (g) Membrane Type of Blood ACT (s) 
Non-porous SED 0.486 
Non-porous TPU 
film 
Activated 161 
Porous SED 0.502 Porous TPU film Activated 122 
Non-porous SED 0.488 
Non-porous TPU 
film 
Citrated >1500 
Porous SED 0.498 Porous TPU film Citrated >1500 
 
 
 
Activated blood was used for some samples. To activate the blood 105 μL of 0.1 
M CaCl2 was added to every mL of bovine blood to achieve an activated clotting time 
(ACT) of 120 – 180 s [3]. ACT was checked by adding 2 mL of blood into kaolin-activated 
test vials and inserting the vials into a Hemochron® 401 (International Technidyne 
Corporation, Edison, NJ, USA).  
 SEDs were rinsed in PBS immediately prior to incubation in the containers 
containing blood. SEDs were submerged in citrated blood for 1 hour, and 30 minutes in 
activated blood. The SEDs were then removed, rinsed gently with PBS to wash away non-
adherent thrombus, imaged, and dried overnight in a 50°C oven. A control foam was 
placed in the oven alongside the clotted devices to ensure the devices were thoroughly 
dried. Once dried the SEDs were weighed to quantify the mass of clot/blood on the device. 
Devices were then imaged again, and prepared for SEM.  
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4.1.3 Delivery into an anatomical model 
 
 An anatomical model based on computed tomographic (CT) images of a human 
LAA was fabricated to test the SEDs. CT image data of a human heart was acquired 
through OsiriX image library [50]. The left atrium and LAA were then isolated utilizing 
image thresholding tools on the 3D Slicer platform developed by NIH (Figure 4.1) [51]. 
A surface mesh of the model was then created and further processed with MeshLab 
software [52]. The surface mesh was verified to ensure it was watertight and had a 
minimum wall thickness to enable 3D printing. Isolating the LAA from CT data and 
converting it to a mesh is shown in Figure 4.1. 
 The isolated left atrium and LAA mesh was then 3D printed. The 3D printed model 
was then vapor polished with acetone. The 3D printed model was then placed into a box 
with smooth walls, and had polydimethylsiloxane (PDMS) casted around it. The PDMS 
was allowed to cure in a pressure chamber overnight, followed by a final cure in an oven 
set at 50°C for an hour. The mold was then placed into a heated base bath to dissolve the 
printed material from the PDMS cast. The final result was a PDMS model in the shape of 
the desired vessel geometry.  
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Figure 4.1: (A) Isolating target vessel geometry from CT data; (B) processed mesh suitable for 3D 
printing. 
 
 
 
 SEDs were pre-loaded in PTFE tubes and were delivered into anatomic models 
under minimal flow at body temperature. Devices were deployed in a similar manner 
described in Section 3.1. Once the devices were deployed and fully actuated the ability to 
recapture them was investigated. Additionally, the device detachment was investigated by 
unscrewing the delivery cable from the SEDs.  
 
 
4.1.4 Device-ostium apposition 
 
 Fully actuated devices deployed within the anatomical models were imaged to 
quantify any gaps between the device and appendage ostium. To do this, a protocol 
described by Siewiorek et al. was used [40]. Briefly, the occluded models were positioned 
so the device and ostium were perpendicular to the camera’s lens. Images were taken of 
the occluded model, along with a scale. The cross-sectional areas of the ostium and device 
were then measured with ImageJ. The device-ostium apposition was then quantified by 
taking the ratio of the ostium and device cross-sectional areas.   
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4.1.5 Particulate quantification 
 
 Particle counting by light microscopy was performed to quantify the particles 
generated by SMP foam, SEDs with a porous membrane, and SEDs with a non-porous 
membrane (N = 2). Mechanically-reticulated, non-cleaned SMP foams (30 mm OD; 20 
mm length) were used as samples, and to fabricate SEDs. To improve visualization of the 
particles, foam was dyed following a protocol specified in Appendix E. The particle 
counting protocol used in this thesis was adapted from the USP 788 microscopic particle 
count test and is shown in Figure 4.2 [15]. 
Briefly, samples were crimped and then placed into clean glassware containing 
100 mL of particle-free water. The samples were then placed into a water bath set to 37°C 
for an hour under sonication to actuate the devices. The containers were then removed, 
inverted 20 times, and the contents passed through a cellulose filter under vacuum. The 
filter holder was then rinsed with 10 mL of particle-free water to re-suspend any particles 
adhering to the filter holder wall. Once the filter was free of water, the vacuum was 
stopped and the filter was carefully removed and placed onto a clean glass slide for further 
analysis.  
 
 
 
 48 
 
 
 
Figure 4.2: Schematic representation of the particle counting procedure.  
 
 
 
 Once the filter was dried, the filter was placed under a Keyence light microscope 
at a 100x magnification and examined. To count the particles, the Keyence systems “auto-
measurement” software was used. The majority of the filter was analyzed by 
systematically moving the filter. Some filters were then analyzed under SEM by allowing 
them to dry at 80°C overnight, and sputter coating the surface of the filter with gold.  
 Results were compared to the acceptance criteria specified by USP 788 for small-
volume (<100 mL) injections (Table 4.2). USP 788 identifies different acceptance criteria 
depending on the method of particle counting (e.g. light obscuration method vs 
microscopic particle count test).  
 
 
 
Table 4.2: USP 788 acceptance criteria for injection or parenteral infusion for small volumes (< 
100mL) [15].   
Method ≥ 10 μm ≥ 25 μm 
Light obscuration 6000 600 
Microscopic particle count test 3000 300 
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To ensure the test environment did contribute significant amounts of particulate 
matter samples consisting of particle-free water were counted. The acceptable limits for a 
100 mL sample of particle-free water are specified in Table 4.3. If the particle count is 
greater than the specified limits then the test environment is not suitable for particulate 
analysis.  
 
 
 
Table 4.3: USP 788 limits for particle-free water per 100 mL sample [15]. 
Method ≥ 10 μm ≥ 25 μm 
Light obscuration 100 20 
Microscopic particle count test 40 10 
 
 
 
4.2 Results 
 
4.2.1 SED expansion 
 
 SEDs were capable of being crimped to fit within a 12 Fr catheter (ID ≤ 3.75 mm). 
By encapsulating the SMP foam within a TPU film the crimped diameter was increased, 
on average, by 0.42 ± 0.07 mm. The effect of bore size on crimped diameter is shown in 
Figure 4.3.  
The crimped diameter reported in Figure 4.3 includes the 0.008” nitinol wire 
threaded through the device, which was done to perform actuation studies. The crimped 
diameter is expected to decrease by 0.008” (0.20 mm) when fabricated without the nitinol 
wire. Actuation studies were performed on non-porous devices with an unestablished 
fabrication protocol, and therefore was omitted from this thesis. However, qualitative 
visual inspection of SEDs actuating during in-vitro studies resulted in full expansion in 
under 8 minutes (see section 4.2.4).  
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Figure 4.3: Crimped diameter of SEDs as a function of bore diameter. SEDs were fabricated with 
foams with medium sized pores, and crimped over a 0.008” nitinol wire (N = 2).  
 
 
 
4.2.2 Device-blood interaction 
 
 Gravimetric analysis and qualitative images show SEDs were able to form clots 
and/or adsorb blood components. All devices were able to fully actuate when submerged 
in bovine blood, with the exception of a SED with a non-porous membrane that was 
submerged in activated bovine blood. The non-porous SED submerged in activated blood 
did not fully actuate because blood was not able to penetrate the device and depress the Tg 
before becoming clotted.  
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Thrombus formed in the gaps between SMP foam and the membrane (Figure 
4.4A). This is beneficial as the additional thrombus may improve volumetric filling of the 
target vessel and prevent SMP particles from entering circulation. No blood clots formed 
on devices submerged in citrated blood. However, citrated blood was adsorbed throughout 
the entirety of the devices (Figure 4.4C, D). Table 4.4 shows a major difference between 
the mass of clot formed on porous and non-porous SEDs. The mass of a control foam was 
recorded prior to submerging it in water and after drying it alongside clotted foams to 
verify all moisture was removed.  
 
 
 
Table 4.4: Results of submerged SED samples in bovine blood (N = 1). 
Sample 
Description 
Blood Status Initial Mass (g) Dried Mass (g) % Change 
Non-porous SED Activated 0.486 0.568 16.9 
Porous SED Activated 0.502 1.23 145 
Non-porous SED Citrated 0.488 1.31 168 
Porous SED Citrated 0.498 1.49 201 
Control foam N/A 0.420 0.410 -2.42 
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Figure 4.4: (A) SED with porous membrane submerged in activated bovine blood; (B) SED with non-
porous membrane submerged in activated bovine blood; (C) SED with porous membrane submerged 
in citrated bovine blood; (D) SED with non-porous membrane submerged in citrated bovine blood. 
(A.1, B.1, C.1, D.1) Devices imaged immediately after removal from blood; (A.2, B.2, C.2, D.2) outer 
surface of devices imaged after drying; (A.3, B.3, C.3, D.3) cross-sectional images of devices after 
drying.  
 
 
 
 SEM analysis revealed signs of thrombus-related events on SMP foam and TPU 
films that were submerged in activated bovine blood (Figure 4.5). On both SMP foam and 
TPU film surfaces droplet-like formations appeared. These droplet-like formations are 
thought to be related to the oven-drying procedure. Additionally, what appears to be 
platelet clusters intertwined with fibrin is observed on the surfaces of both SMP foam and 
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TPU film. Kawasaki et al. show SEM images of platelets that have similar morphology to 
the platelet clusters observed in this study [53].  
 
 
 
 
Figure 4.5: SEM images of thrombus-related materials on (A) TPU film and (B) SMP foam. 
Arrowhead indicates possible platelet cluster. 
 
 
 
4.2.3 Device delivery 
 
 More than half of all the devices were delivered without complications and 
expanded to fill the ostium of the appendage in < 8 minutes (Figure 4.6). The majority of 
the complications were a result of insufficient radial force from the device to keep them 
fixed in the anatomic model. As a result, the device rotated with the detachment 
mechanism during deployment. Transitioning from a #4-40 to #0-80 screw improved the 
results, but ultimately the devices will have to be fixed in the anatomy to be practical. This 
can be achieved by incorporating nitinol, shape memory polymer, or coils to the device to 
anchor it to the vessel.  
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 Unsheathing the device from the delivery catheter proved difficult at times. Parts 
of the device and delivery cable lacked column strength, and as a result the delivery cable 
would buckle or bend. Fortunately, switching to a stiffer delivery cable improved results. 
 Attempts to recapture fully expanded devices were unsuccessful. The devices were 
simply too large to fit inside the delivery catheter. Partial recapture (i.e. capturing half the 
device) was possible. Incorporating a metallic or polymeric frame around the devices may 
enable full recapturing in future device generations.  
 
 
 
 
Figure 4.6: Benchtop delivery of SED. (A) A pre-loaded mock catheter is positioned into the LAA (B) 
the mock catheter is retracted while the SED and delivery cable are held in place (C) the SED is 
allowed to expand (D) the SED is detached from the delivery cable. 
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4.2.4 Device-ostium apposition  
 
 Gaps between the device and LAA ostium were quantified via image processing 
(Figure 4.7). All device geometries were able to occlude at least 86% of the ostium, with 
a majority of devices able to occlude roughly 95% of the ostium. Peri-device flow has 
been observed in roughly 32% of patients, and is considered to be insignificant if the leak 
is < 5 mm [54-57]. Ideally, there should be no gaps between the device and ostium in order 
to prevent any emboli from entering systemic circulation and to improve 
endothelialization. 
 
 
 
 
Figure 4.7: Device-ostium apposition of a 30 mm SED in benchtop model. The red indicates gaps 
between the device and the ostium. 
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 Ostium geometry may limit the effectiveness of left atrial appendage closure 
devices. To determine if the benchtop models geometry was aggressively difficult when 
compared to clinical cases the “irregularity index” was calculated. The irregularity index 
correlates ostium geometry to residual leaks [58]. To calculate the irregularity index, the 
real and ideal area of the ostium are first recorded. The real area of the ostium is measured 
with any image processing software. The ideal area is calculated by measuring the major 
and minor axes of the ostium and using the following equation:  
𝐼𝑑𝑒𝑎𝑙 𝑎𝑟𝑒𝑎 =  𝜋 ∙ 𝑚𝑎𝑗𝑜𝑟 𝑟𝑎𝑑𝑖𝑢𝑠 ∙ 𝑚𝑖𝑛𝑜𝑟 𝑟𝑎𝑑𝑖𝑢𝑠   
The irregularity index is then calculated by the following equation: 
𝐼𝑟𝑟𝑒𝑔𝑢𝑙𝑎𝑟𝑖𝑡𝑦 =  𝑎𝑏𝑠[1 − (𝐼𝑑𝑒𝑎𝑙 𝐴𝑟𝑒𝑎 𝑅𝑒𝑎𝑙 𝐴𝑟𝑒𝑎⁄ )]   
An irregularity index of 0.04 was identified as a threshold to predict a leak with a 
specificity of 94%. The irregularity index of the benchtop model in this study was around 
0.027, which means the geometry of the benchtop model is not particularly irregular. In 
other words, the benchtop models geometry should be suitable for treatment. Since the 
SEDs did not completely seal the ostium, they may need to be more over-sized to conform 
to the ostium. 
 
 
4.2.5 Particulate generation 
 
 The distribution of particles is shown in Table 4.5 and Figure 4.8. The low amount 
of particles generated from particle-free water verifies the test environment is suitable for 
particulate analysis (limit ≥ 10 μm = 40, ≥ 25 μm = 10). A significant reduction in the 
number of particles was observed when SMP foam was encapsulated in a membrane. The 
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porous SEDs were compliant with the limits defined by the USP 788 light obscuration 
method (limit ≥ 10 μm = 6000, ≥ 25 μm = 600). However, the porous SEDs were not 
compliant with the limits defined by the USP 788 microscopic method, despite being close 
(limit ≥ 10 μm = 3000, ≥ 25 μm = 300). It is expected the devices would be compliant if 
they were cleaned and handled properly, and if the membrane pore size was decreased 
from 261 μm. Furthermore, the method of counting was performed with image analysis 
software that may have inflated the particle count. 
 
 
 
Table 4.5: Mean ± standard deviation of particles counted for particles ≥ 10 μm and ≥ 25 μm. 
Sample (N = 2) ≥ 10 μm ≥ 25 μm 
Particle-free water 33.00 ± 8.485 8.500 ± 2.121 
Foam 6057 ± 567.1 1805 ± 65.76 
Porous SED 896.5 ± 129.4 372.0 ± 110.3 
Non-porous SED 1934 ± 183.1 680.0 ± 306.9 
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Figure 4.8: Number of particulates counted from particle-free water, SMP foam, a non-porous SED, 
and a porous SED. Asterisks indicate a significant difference (p < 0.05) when compared to SMP foam. 
 
 
 
The main objective of this study was to compare the particle levels between a foam 
and a SED, and verify if there was a reduction of particles. Figure 4.8 shows a significant 
reduction of particles between foam and devices, highlighting the utility of encapsulating 
foams. Interestingly, the non-porous SED samples generated more particles than the 
porous SED samples. This result was unexpected, considering the non-porous SEDs 
should not allow any encapsulated foam particles from escaping. Potential causes for the 
discrepancy include the handling of the samples and membrane tears. All samples were 
handled in ambient air and crimped in a non-sterile stent crimper that was not cleaned 
between samples. Furthermore, the non-porous SEDs were air-tight and could have burst 
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when crimped, similar to squeezing a balloon. The membrane was perforated with a needle 
a few times to prevent bursting, but could have been ineffective. 
 
 
 
 
Figure 4.9: SEM images of (A) filter membrane and (B) particles on filter membrane.  
 
 
 
Based on SEM and light microscopy images, the largest particles were fractured 
struts that were long but narrow. Numerous particles composed of thin SMP cell 
membranes were also observed (Figure 4.9). The SMP cell membranes were typically 
trapezoidal and came in many different sizes that were less than 200 μm. The amount of 
particles composed of cell membranes would be expected to drop if the SMP foam was 
reticulated and thoroughly washed [26]. 
Micro-embolization of cerebral arteries is an inherent risk for embolic protection 
devices and for the SEDs described in this thesis [59]. Matsuda et al. have reported stroke 
victims show pathological evidence of occluded arterioles ranging from 50 to 300 μm 
[60]. The danger of micro-embolization is further supported by a series of patients who 
developed neurologic dysfunction following a cardiac procedure. These patients died 
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shortly after and autopsy revealed acellular material (< 70 μm), believed to be emboli, 
deposited in their cerebral microvasculature [61]. Despite the risk of micro-embolization, 
the SEDs reduce the risk of macro and micro-embolization relative to a non-encapsulated 
SMP foam. A reduction of the SED’s membrane pore size, in conjunction with improved 
filter design and proper cleaning, is expected to improve the capture of particles.  
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5. CONCLUSIONS AND FUTURE WORK 
 
5.1 Summary 
 
 SMP foams have been used in endovascular applications due to their ability to 
volumetrically fill body cavities after being deployed via catheter. These foams, however, 
pose a risk of generating harmful particulates that can cause unintended ischemia. The risk 
of generating harmful particulates is further increased when SMP foam is in contact with 
nitinol, or other hard materials that are common in endovascular devices. The main 
objective of this thesis was, therefore, to mitigate the risk of SMP foams generating 
particulates. To do this a sheathed embolization device (SED) was designed, fabricated, 
and tested in the context of closing left atrial appendages (LAAs). Left atrial appendage 
closure (LAAC) was chosen as the intended application for the device because predicate 
devices are composed of nitinol, and if this device is successful could be integrated with 
predicate devices. Furthermore, LAAC is of great commercial and research interest in the 
Biomedical Device Lab. 
 In Chapter 2, the SMP foams used to develop SEDs were characterized. A main 
concern for the development of a SED for LAAC was determining a method to allow SMP 
foam to undergo a 10x diameter expansion. SMP foams were needed to expand to an OD 
of 30 mm following delivery from a 12 Fr catheter; which roughly corresponds to a 10x 
diameter expansion. To do this, cylindrical SMP foams were bored, or hollowed, in the 
center in an effort to increase the expansion ratios. Results showed that SMP foams were 
able to reach a 10x expansion when a 20 mm hole was punched through the center. 
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Increasing the pore size and bore size increased the expansion ratio of SMP foam due to 
the decrease in foam density. Regardless of pore or bore size, all SMP foams were able to 
expand to 30 mm or greater from a compressed state when placed in body temperature 
water.  
 Chapter 3 reviewed the design and fabrication of a SED. The final design chosen 
consisted of a SMP foam encapsulated in a porous TPU film that had stainless steel tubes 
epoxied to both ends. To deliver and deploy the SED, a simple screw-mechanism was 
designed and fabricated. TPU films were chemically, thermally, and morphologically 
characterized. ATR-FTIR confirmed the presence of polyurethane in the TPU films, and 
also revealed one of the films was a polyether-polyurethane film. DSC revealed the TPU 
films had a Tg below freezing. The low Tg allows the films to expand in tandem with SMP 
foam when placed into the body, however, it also means the films may not hold their 
crimped geometry. SEM analysis of the as-received TPU films revealed they were 
monolithic and impermeable to water. Thus, a CO2 laser created uniform 261 μm pores 
into the TPU film to enable blood and cells to penetrate the SMP foam. The film was 
molded into a closed-end cylinder by placing wrapping it around foam and heat-sealing 
the ends. The stainless steel tubes epoxied to the ends of the device enable fluoroscopic 
imaging, and aid in delivering the device. 
 Chapter 4 tested the devices ability to be delivered via a 12 Fr catheter, occlude a 
LAA, reduce particles, and its ability to undergo actuation in blood and adsorb blood. 
Devices were capable of fitting within a 12 Fr catheter. Crimped devices were submerged 
into citrated and activated bovine blood and showed excellent actuation, suggesting that 
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under in-vivo conditions the device will actually expand to occlude the cavity. Devices 
also doubled their weight in adsorbed blood. Visual inspection revealed clotted bovine 
blood between the SMP foam and the TPU films, and that blood was able to penetrate 
deep within the foam. These results suggest that thrombus, in addition to SMP foam, may 
aid in occluding body cavities.  
 Devices were able to be successfully delivered into an anatomical model. Several 
observations were made that could improve device delivery including anchoring the 
device in the appendage, fabricating stiffer devices, and using a stiffer delivery cable. Gaps 
between the LAA ostium and devices were measured via image processing. Gaps between 
the device and ostium accounted for 4 to 14% of the ostium surface area.  
 A protocol based on USP 788 was adapted to count the number and size of particles 
that were generated as SMP foam actuated with or without a membrane. Results showed 
that encapsulating SMP foam in a TPU film significantly reduced the number of particles. 
SEM of the particles revealed troublesome particles composed of long and narrow foam 
struts, and thin cell membranes.  
 
 
5.2 Challenges and future work 
 There were many limitations throughout the development of this thesis that I will 
briefly discuss in chronological order. To minimize the crimped diameter of the foam the 
centers were bored out. Sacrificing foam materials may inhibit healing, limit actuation, 
and reduce the radial expansion force of the foam. Limited actuation and radial expansion 
force could cause inadequate sealing and foam migration inside the body. Future studies 
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should include measuring the radial force of SEDs, and comparing the radial force to 
similar device. An alternative to boring out foam may be to increase the crimping pressure. 
However, the ability of water or blood to plasticize the foam may be restricted due to the 
tighter crimping pressure and affect expansion rates. 
 Finding a suitable material to encapsulate the SMP foam was the most difficult 
challenge of this thesis. Initially, PET (i.e. Dacron) was investigated because of its history 
in predicate devices. However, PET was a stiff, non-elastic material that would not expand 
from a crimped state. TPU films were then investigated and served their purpose but were 
still not the ideal material. As received TPU films were not porous, and did not retain their 
crimped geometry for extended periods of time. Furthermore, processing the TPU films 
to form porous cylinders resulted in seam-lines, rough edges, and large pores. Future work 
could include synthesizing porous SMP films with tailored transition temperatures. The 
SMP films could be thermoset or thermoplastic, but thermosets are expected to be much 
more difficult to process. Furthermore, work would need to be done to determine an 
optimal porosity. These films could even be surface-modified to be non-thrombogenic or 
loaded with drugs or growth factors.  
 Another significant challenge within this thesis included counting particles with 
light microscopy. For the most part, the USP 788 outlined protocol was strictly followed. 
However, upon analysis, the particles were difficult to differentiate from the filter 
background. To improve manual particle counting, black filter membranes may be used 
to improve the contrast against the white foam particles. Alternatively, foams may be 
dyed. Furthermore, manually counting the entirety of the filter is labor-intensive and not 
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practical. Fortunately, the microscope used in this study had built-in software to automate 
particle counting; though, it was never verified. The particle counting method should be 
verified by counting a known amount of calibrated particles, and ensuring a reasonable 
percentage of the calibrated particles are recovered.   
Another challenge included delivering the devices under physiological conditions. 
In this thesis the devices were delivered into thick-walled PDMS anatomical models at 
body temperature with minimal flow. Ideally, the delivery would be performed under 
physiological conditions such as pulsatile flow with a blood-like fluid into an anatomical 
model that has similar mechanical characteristics of the natural anatomy. The delivery 
could even be performed under fluoroscopic guidance to verify the device can be 
positioned under clinical conditions. Lastly, the force to deliver devices through a catheter 
should be measured.  
Following deployment of the SEDs in the benchtop model, it was observed the 
devices were not fixed and could easily migrate out of the appendage. To prevent device 
migration the devices should be augmented with super-elastic alloys or polymers, or coils. 
Furthermore, the force required to dislodge the devices once deployed in the model should 
be quantified. 
A major motivation of this thesis was to reduce the generation of foam particles 
due to interaction with nitinol and hard materials. Future work would be to integrate SEDs 
with nitinol, and to repeat many of the tests outlined in this thesis.  
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APPENDIX A 
MECHANICAL PROPERTIES OF SMP FOAM AND THERMOPLASTIC 
POLYURETHANE FILM 
 
Methodology 
 
The mechanical properties of thermoplastic polyurethane (TPU) film and non-
cleaned and non-reticulated H40 foams were investigated. The pore sizes of the foams 
ranged from small, medium, and large; which corresponded to 1000, 1500, and 1800 μm 
pore sizes, respectively. The mechanical properties of the TPU films were taken from the 
manufacturer’s website, whereas the mechanical properties of foam were characterized 
following the ASTM D638 standard for non-rigid samples [62]. 
 To characterize the foams they were first sliced to a thickness ≤ 4mm. A calibrated 
and certified ASTM D638 Type IV cutter (Pioneer-Dietecs Corporation, Weymouth MA) 
was used to punch dog bone samples from the foam slices. The ends of the dog bone 
samples were then epoxied to wooden stubs so they can be attached to the tensile tester’s 
grips. The dog bone samples were then allowed to dry overnight in a vacuum oven. Dried 
dog bone samples were then loaded onto an Insight 30 material tester (Materials Testing 
Solutions, MTS Systems Corporation, Eden Prairie, MN), and strained until failure. Each 
composition was tested at least four times for reproducibility.  
 
 
 
 
 
 
 73 
 
 
Results 
 
 Table A-1 and Figure A-1 summarize the key mechanical properties for TPU film 
and H40 foam, respectively. The TPU film and H40 foam had similar tensile strengths. 
Foam pore size significantly affected the strain at break and modulus of foam. Foams with 
a smaller pore size possessed a lower modulus and were more flexible in a dry state when 
compared to their larger pore counterparts. Therefore, a small pore foam may enable easier 
delivery through tortuous anatomy and not fracture as readily. Fracture may occur under 
extreme strain of the foam, which may occur as the foam is retracted into the catheter. 
However, no conclusions can be determined at this time since these results reflect the 
mechanical properties of dry, non-processed foam, and not the mechanical properties of 
the wet, processed foam used in the clinical setting.  
 
 
 
Table A-1: Key mechanical properties of the TPU film compositions used to fabricate SEDs. Taken 
from [62]. 
Mechanical Property AU25 TPU Film EU28 TPU Film EU29 TPU Film 
Thickness (μm) 23 28 27 
Tensile Strength (MPa) 0.079 0.10 0.079 
Elongation at Break % 400 650 500 
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Figure A-1: (A) Toughness, (B) ultimate tensile strength, (C) strain at break, and (D) modulus of H40 
foam for varying pore sizes. Small, medium, and large corresponds to a pore size of 1000, 1500, and 
1800 μm, respectively. Mean ± standard deviation displayed; N ≥ 4; *p<0.05 relative to small pore 
foam; **p<0.05 between the bracketed groups. 
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APPENDIX B 
SUMMARY OF ACTUATION SOFTWARE 
 
Purpose 
 
 The purpose of developing software was to expedite the process of determining 
the actuation profiles of SMP foam. Actuation profiles of SMP foams simply refers to the 
change in shape of SMP foam as a function of time. Prior to the development of this 
software determining the actuation profiles of SMP foams was a manual-intensive process 
that could take upwards of 30 minutes and result in variability depending on the user.  
 
Description of software 
 
 The software was developed with MATLAB (MATLAB R2015b, The MathWorks 
Inc., Natick, MA, 2000). A graphical user interface (GUI) was made using MATLAB’s 
built-in features, and allows the user to interactively and intuitively process their images 
(Figure B-1). Briefly, execution of the program brings up a main interactive screen 
(Figure B-1A). The user then uploads all the images to be analyzed. The user then sets a 
scale that relates pixels to units of length by first entering the known distance then 
measuring the reference in a pop-up figure (Figure B-1B). The user then marks a region 
of interest around the target of interest (e.g. SMP foam changing shape) (Figure B-1C). 
The region of interest essentially disregards everything outside the region and improves 
accuracy. The user then selects “Gray Thresh”, which isolates the target of interest from 
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background based on gray-scale intensity values (Figure B-1D). The user may fill pores 
or holes that are present following thresholding (Figure B-1E). 
The technical details of the program can be summarized as follows: the isolated 
target of interest (e.g. SMP foam) is converted to a binary image and the 2-D projected 
surface area is calculated; the surface area is then divided by the length of the target of 
interest to determine the diameter; the diameter is plotted against time and displayed to 
the user. The program then exports processed image files and an excel spreadsheet to a 
user-specified folder. Throughout the process the degree of automation can be managed 
by the user.  
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Figure B-1: Interactive GUI to analyze actuation image data: (A) Main user interface (B) figure pop-
up to allow user to set scale and measure length of foam (C) figure pop-up to allow user to set region 
of interest (D) figure pop-up to allow user to isolate foam from background based on gray-scale values 
(E) figure pop-up to allow user to fill in holes.   
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APPENDIX C 
VERIFICATION OF ACTUATION SOFTWARE 
 
Scope 
 
The purpose of verifying software, in general, is to demonstrate the software is 
consistent, complete, and correct: verification answers the question “is the software built 
right?”. Whereas software validation demonstrates that the software is built according to 
the user requirements and answers the question “did we build the right system?”. Within 
this thesis software was developed via MATLAB to allow users to extract measurements 
from images; in particular, the software extracted the average diameters of foam as a 
function of time. The software was developed to dramatically reduce time when analyzing 
these image sets. To verify the software, manual measurements were compared to software 
generated measurements.  
 
 
Method 
 
Software verification was performed by comparing measurements taken manually 
and via the software. To do this, images of SMP foam changing shape in a water bath set 
at 37°C were taken with a digital camera (PowerShot SX230 HS, Canon Inc., Tokyo, 
Japan) every 30 seconds.  
Manual measurements were taken with ImageJ (NIH, Bethesda, MD) open-source 
software. Each image was analyzed with ImageJ by first setting a scale that relates pixels 
to a unit of length, then measuring the width of the foam across its length at 15-20 evenly 
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spaced locations. The width measurements were then averaged to determine the average 
diameter of the SMP foam at that specific time point. These measurements were then 
repeated until the entire image set was analyzed. Semi-automated measurements were 
taken with the MATLAB program described in Appendix B. Global settings were applied 
when analyzing images in the MATLAB program, as opposed to individual settings (e.g. 
individual thresholding vs. universal thresholding).  
 
 
Results and discussion 
 
Manual and semi-automated measurements taken with ImageJ and the MATLAB 
program were plotted against each other to determine if there is a relationship between the 
two methods. Figure C-1 shows a positive linear correlation between both methods of 
measurements (R2 > 0.99). Two samples with different actuation profiles were 
investigated to demonstrate the robustness of the program. Furthermore, the samples used 
in this verification study were SED’s, which added complexity to the measurements due 
to the varying degrees of contrast in the images. Verification was also performed on 
individual SMP foams (not shown), and also demonstrated a positive linear correlation 
between both methods. The results presented herein demonstrate that the semi-automated 
MATLAB program can be used in substitution of manual measurements to expedite 
actuation analysis.  
 80 
 
 
 
Figure C-1: Comparison of SED diameter as measured by manually (ImageJ) or automatically 
(MATLAB program).   
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APPENDIX D 
FOAM EXPANSION ANALYSIS 
 
Scope  
 
An index was calculated to identify if pore size or bore size affected foam 
expansion. The index was taken as the time at which the foam was 50% expanded. The 
index was then compared as a function of pore and bore size.  
 
 
Method 
 
 An exponential or polynomial curve was fitted to the experimental ‘diameter vs 
time’ data. Using the equation corresponding to the fitted curves, the time at which the 
foam expanded to 50% of its final diameter was calculated.  
 
 
Results 
 
 A two-way ANOVA was performed to determine if pore or bore size significantly 
affected the index, and as a result, the expansion rate of foams. Results show no statistical 
significance due to either bore or pore size. Figure D-1 shows the averaged index as a 
function of bore and pore size.   
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Figure D-1: The time for foam to reach 50% of its expanded diameter, referred to as “index”, as a 
function of pore and bore size (N ≥ 2). 
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APPENDIX E 
DYEING POLYURETHANE FOAM 
 
Scope  
 
To improve manual and automated counting of particles using the microscope 
method the contrast between the particles and background should be sufficient. This can 
be achieved by purchasing colored filters or, alternatively, dyeing the particles. In this 
research, polyurethane foams were dyed to improve particle counting.  
 
 
Method 
 
A protocol based on Baldez et al. was adapted to dye our polyurethane foams [63]. 
Briefly, a solution of sodium dodecyl sulfate (SDS) and Nile Blue (NB) was made at a 
molar concentration of 4:1, respectively. Polyurethane foams were then placed into the 
solution and gently stirred for at least 100 minutes to allow uptake of dye. The foams were 
then removed, blotted, and then placed into an oven at 80°C overnight to dry. Following 
drying the foams can be rinsed to remove residual dye, or used as is.  
 
